Identification of Insulin-producing Cells Derived from Embryonic Stem Cells by Zinc-chelating Dithizone
Overview
Reproductive Medicine
Authors
Affiliations
Background And Aims: Embryonic stem (ES) cells have a pluripotent ability to differentiate into a variety of cell lineages in vitro. We have recently identified the emergence of cellular clusters within differentiated ES cell cultures by staining with dithizone (DTZ). DTZ is a zinc-chelating agent known to selectively stain pancreatic beta cells because of their high zinc content. The aim of the present study was to investigate the characteristics of DTZ-stained cellular clusters originating from ES cells.
Methods: Embryoid bodies (EBs), formed by a 5-day hanging drop culture of ES cells, were allowed to form outgrowths in the culture. The outgrowths were incubated in DTZ solution (final concentration, 100 microg/ml ) for 15 minutes before being examined microscopically. The gene expression of endocrine pancreatic markers was also analyzed by reverse transcriptase-polymerase chain reaction. In addition, insulin production was examined immunohistochemically, and its secretion was examined using enzyme-linked immunosorbent assay.
Results: DTZ-stained cellular clusters appeared after approximately 16 days in the EB culture and became more apparent by day 23. They were found to be immunoreactive to insulin and expressed pancreatic-duodenal homeobox 1 (PDX1), proinsulin 1, proinsulin 2, glucagon, pancreatic polypeptide, glucose transporter-2 (GLUT2), and islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) mRNA. They were also able to secrete detectable amounts of insulin.
Conclusions: ES cell-derived DTZ-positive cellular clusters possess characteristics of the endocrine pancreas, including insulin secretion. Further, DTZ staining is a useful method for the identification of differentiated pancreatic islets developed from EBs in vitro.
Enhancing the Functionality of Immunoisolated Human SC-βeta Cell Clusters through Prior Resizing.
Bochenek M, Walters B, Zhang J, Fenton O, Facklam A, Kronekova Z Small. 2024; 20(23):e2307464.
PMID: 38212275 PMC: 11153032. DOI: 10.1002/smll.202307464.
Yasmin I, Dharmarajan A, Warrier S Cancers (Basel). 2023; 15(14).
PMID: 37509281 PMC: 10377620. DOI: 10.3390/cancers15143622.
Abuarqoub D, Adwan S, Zaza R, Wehaibi S, Aslam N, Jafar H Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242432 PMC: 10222296. DOI: 10.3390/ph16050649.
Hosseini S, Hashemi-Najafabadi S, Bagheri F Prog Biomater. 2022; 11(3):273-280.
PMID: 35802251 PMC: 9374854. DOI: 10.1007/s40204-022-00194-7.
Zhang S, Wang Q, Ji H, Lu H, Yang Q, Yin J Mol Med Rep. 2021; 24(4).
PMID: 34414446 PMC: 8404098. DOI: 10.3892/mmr.2021.12377.